{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Last month, the Bill and Melinda Gates Foundation pledged $43 million to efforts by a California biochemist to genetically re-engineer bacteria to grow a malaria drug normally grown in six-foot-tall plants in Asia. Also, recently, the Medicines for Malaria Venture, a public-private partnership in Geneva, said that the leading candidate among 21 next-generation drugs it was testing was a synthetic trioxolane known for the moment as OZ277, or just ''Oz.''", "headline": {"main": "Millions of Lives on the Line in Malaria Battle"}, "abstract": "Search for malaria cures is continuous endeavor involving multiple approaches; Dr Dyann Wirth, Harvard Malaria Initiative head and infectious disease specialist, describes how sequencing DNA of malaria has opened up new avenues for research; Dr Jay Keasling, who recently received funding from Bill and Melinda Gates Foundation, is working to genetically re-engineer bacteria to grow malaria drug that is naturally derived from wormwood plant; other research projects and scope of malaria discussed; photo (M)", "print_page": "6", "word_count": 1213, "_id": "4fd2443c8eb7c8105d7de4fe", "snippet": "The search for new cures for malaria is never ending.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/policy/25mala.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KEASLING, JAY"}, {"name": "persons", "value": "WIRTH, DYANN"}, {"name": "organizations", "value": "HARVARD UNIVERSITY"}, {"name": "organizations", "value": "GATES, BILL AND MELINDA, FOUNDATION"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "WORMWOOD"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "BACTERIA"}, {"name": "subject", "value": "MALARIA"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DNA (DEOXYRIBONUCLEIC ACID)"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "THE CLAIM: Wearing glasses can weaken your eyes. THE FACTS -- Glasses can bring a blurry world into focus, but some people suspect that by doing all the heavy lifting the glasses may speed the natural decline of vision. But ophthalmologists say this is an illusion.", "headline": {"main": "REALLY?"}, "abstract": "Research does not support idea that wearing glasses weakens vision; drawing (S)", "print_page": "5", "word_count": 195, "_id": "4fd257188eb7c8105d80103b", "snippet": "THE CLAIM: Wearing glasses can weaken your eyes.    THE FACTS -- Glasses can bring a blurry world into focus, but some people suspect that by doing all the heavy lifting the glasses may speed the natural decline of vision. But ophthalmologists say...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F0CE3DE1F38F936A15752C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "RAY, C CLAIBORNE"}, {"name": "subject", "value": "EYEGLASSES"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "EYES AND EYESIGHT"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Anahad", "rank": 1, "lastname": "O'CONNOR"}], "original": "By ANAHAD O'CONNOR"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "The number of deaths linked to prescription drugs rose fourfold in Utah from 1991 to 2003, a new study reports, attributing the drastic change to a sharp increase in prescriptions for powerful painkillers. In 2003, legal drugs were responsible for almost three times as many deaths as illegal narcotics, even when suicides were not counted.", "headline": {"main": "Mortality From the Pharmacy", "kicker": "VITAL SIGNS: TREATMENTS"}, "abstract": "Dr Christy Porucznik, Centers for Disease Control and Prevention official with Utah Department of Health, discusses findings published in Morbidity and Mortality Weekly Report that show increase in deaths linked to prescription drugs; asserts that reported rise in prescriptions for painkillers may be contributing factor; drugs most often involved were methadone, oxycodone and hydrocodone; drawing (S)", "print_page": "6", "word_count": 259, "_id": "4fd257188eb7c8105d80103a", "snippet": "The number of deaths linked to prescription drugs rose fourfold in Utah from 1991 to 2003, a new study reports, attributing the drastic change to a sharp increase in prescriptions for powerful painkillers.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25trea.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PORUCZNIK, CHRISTY"}, {"name": "glocations", "value": "UTAH"}, {"name": "organizations", "value": "MORBIDITY AND MORTALITY WEEKLY REPORT"}, {"name": "organizations", "value": "CENTERS FOR DISEASE CONTROL AND PREVENTION"}, {"name": "subject", "value": "OXYCODONE (DRUG)"}, {"name": "subject", "value": "DEATH AND DYING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "METHADONE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}, {"name": "subject", "value": "HYDROCODONE BITARTRATE/ACETAMINOPHEN (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "John", "rank": 1, "lastname": "O'Neil"}], "original": "By John O'Neil"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Obesity appears to skew the results of the most common test used to detect prostate cancer, a study released yesterday concluded. According to the study, which was released online and will be published in March in the journal Cancer, earlier research has shown that obese men have a lower survival rate for prostate cancer and that their cancer tends to be diagnosed in more advanced forms.", "headline": {"main": "Obesity May Skew Prostate Test", "kicker": "VITAL SIGNS: TESTING"}, "abstract": "Dr Ian Thompson, University of Texas Health Science Center researcher, leads study on effectiveness of test to determine prostate cancer; study, published in journal Cancer, finds that obese men have PSA test readings that average one-third lower than men of normal weight; hold that lower readings could delay diagnosis; drawing (S)", "print_page": "6", "word_count": 277, "_id": "4fd241528eb7c8105d7d9eca", "snippet": "Obesity appears to skew the results of the most common test used to detect prostate cancer, a new study concluded.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25test.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "THOMPSON, IAN"}, {"name": "organizations", "value": "UNIVERSITY OF TEXAS"}, {"name": "organizations", "value": "CANCER"}, {"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "PROSTATE GLAND"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "OBESITY"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "PSA (PROSTATE-SPECIFIC ANTIGEN)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "John", "rank": 1, "lastname": "O'Neil"}], "original": "By John O'Neil"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "My introduction to floaters came on a sunny September afternoon in the orchard. I was high on a ladder picking Jonagold apples when I felt a pop in my left eye, followed by blurriness. I thought that maybe a branch had slapped across my glasses, dirtying the lens, and I went inside to clean it. But the blurriness -- a sort of floating haze -- persisted overnight. After hearing the symptoms, my ophthalmologist, Dr. William Kirber, diagnosed a posterior vitreous detachment, one of several causes of floaters, sensations that many people describe as specks, bugs or cobwebs floating in their fields of vision. In 85 percent of cases, the floaters caused by posterior detachment are mere annoyances, but when they occur suddenly, immediate medical examination is essential.", "headline": {"main": "When Shadows Float Before Your Eyes"}, "abstract": "Almost 80 percent of human eye is made up of jelly-like vitreous, which often liquifies and shrinks with age; floaters, unidentified floating objects that appear to viewer as cobwebs or small particles and do not dramatically reduce vision, are caused by small bits of optic nerve floating in vitreous; vitreous detachments are more serious concern and should be treated immediately; conditions and treatments described; drawings (M)", "print_page": "6", "word_count": 1132, "_id": "4fd241528eb7c8105d7d9ecb", "snippet": "At some time, most adults experience floaters, sensations that many people describe as specks, bugs or cobwebs floating in their fields of vision.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25floa.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "AGE, CHRONOLOGICAL"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "EYES AND EYESIGHT"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jonathan", "rank": 1, "lastname": "KOLATCH"}], "original": "By JONATHAN KOLATCH"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "A map showing results from the last presidential election is ''remarkably similar'' to a map of the distribution of cases of Lyme disease, a brief article in the current Lancet medical journal points out. The 19 ''blue states'' -- those won by Senator John Kerry -- account for 95 percent of the cases of Lyme disease reported in 2002, they wrote. The disease, caused by bacteria that are carried by deer ticks, is concentrated in the Northeast and Midwest.", "headline": {"main": "Lyme Disease: The Exit Polls", "kicker": "VITAL SIGNS: PATTERNS"}, "abstract": "Drs Robert B Nadelman and Gary P Wormser, New York Medical College epidemiologists, note in Lancet medical journal that map showing distribution of Lyme disease cases resembles voting pattern of 2004 Presidential election; drawing (S)", "print_page": "6", "word_count": 231, "_id": "4fd2a5da8eb7c8105d88d797", "snippet": "A map showing results from the last presidential election is \"remarkably similar\" to a map of the distribution of cases of Lyme disease, a brief article in the current Lancet medical journal points out.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25patt.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WORMSER, GARY P"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "NADELMAN, ROBERT B"}, {"name": "persons", "value": "KERRY, JOHN"}, {"name": "organizations", "value": "NEW YORK MEDICAL COLLEGE"}, {"name": "organizations", "value": "LANCET"}, {"name": "subject", "value": "PRESIDENTIAL ELECTIONS (US)"}, {"name": "subject", "value": "LYME DISEASE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2004"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "John", "rank": 1, "lastname": "O'Neil"}], "original": "By John O'Neil"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "New research released yesterday shows no correlation between personality types and the risk of cancer. The study's lead author, Pernille Envold Hansen, a researcher with the Danish Cancer Society, said that some earlier research that analyzed data on cancer patients had found an association between high rates of disease and two very different personality types: highly extroverted people and people who displayed very little emotion.", "headline": {"main": "Relax, Type A's. If You Can.", "kicker": "VITAL SIGNS: BEHAVIOR"}, "abstract": "Pernille Envold Hansen of Danish Cancer Society leads research into suspected link between Type A personalities and risk of developing cancer; study, which is published in journal Cancer, shows no correlation between personality and cancers (S)", "print_page": "6", "word_count": 289, "_id": "4fd2a5da8eb7c8105d88d798", "snippet": "New research shows no correlation between personality types and the risk of cancer.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25risk.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "HANSEN, PERNILLE ENVOLD"}, {"name": "organizations", "value": "CANCER"}, {"name": "organizations", "value": "DANISH CANCER SOCIETY"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "John", "rank": 1, "lastname": "O'Neil"}], "original": "By John O'Neil"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Twenty years ago, the actor Yul Brynner, dying from lung cancer, told a television audience that what he really wanted to do was to film a commercial that said, ''Now that I'm gone, I tell you: Don't smoke, whatever you do, just don't smoke.'' Brynner was very much alive when he made this statement in January 1985, on ''Good Morning America'' on ABC News. But after he died, in October of that year, he got his wish. The resulting public service announcement remains one of the most memorable antismoking statements ever made.", "headline": {"main": "In Unforgettable Final Act, a King Got Revenge on His Killers", "kicker": "ESSAY"}, "abstract": "Actor Yul Brynner, who died of lung cancer in 1985, was shown following year in anti-smoking commercial, which ranks among most original of public health messages; American Cancer Society used footage from Brynner's interview on Good Morning America, in which he said he wished that after his death he could tell people not to smoke; photo (M)", "print_page": "5", "word_count": 780, "_id": "4fd2443c8eb7c8105d7de4f9", "snippet": "Yul Brynner's 20-year-old message on lung cancer remains one of the most memorable antismoking statements ever.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25essa.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "GOOD MORNING AMERICA (TV PROGRAM)"}, {"name": "persons", "value": "BRYNNER, YUL"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "TELEVISION"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "LUNGS"}, {"name": "subject", "value": "SMOKING AND TOBACCO"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Barron", "middlename": "H.", "lastname": "LERNER", "rank": 1, "role": "reported", "organization": ""}], "original": "By BARRON H. LERNER, M.D"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Interview", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "When Janet Golden was kicking around in utero 53 years ago, pregnant women of her mother's generation were encouraged to enjoy their 5 o'clock cocktails. A martini calmed nerves; a glass of wine helped a woman to sleep. But don't drink too much, obstetricians cautioned: all those empty calories! By the mid-1960's, many obstetricians even believed that alcohol could halt premature labor. As noted by Dr. Golden, now a medical historian at Rutgers University in Camden, N.J., when women arrived at the hospital in premature labor, they were often handed a vodka and orange juice or given alcohol intravenously.", "headline": {"main": "Sorting Out Ambivalence Over Alcohol and Pregnancy", "kicker": "A CONVERSATION WITH: JANET GOLDEN"}, "abstract": "Interview with Janet Golden, author of book Message in a Bottle: The Making of Fetal Alcohol Syndrome, discusses condition in historical context; holds that political, legal, medical and social response to syndrome is inconsistent and places guilt on mothers, who often have alcohol dependency or addiction; labeling of alcohol products and impact on controlling consumption by pregnant women discussed; photo (M)", "print_page": "5", "word_count": 1464, "_id": "4fd2809e8eb7c8105d84c433", "snippet": "In her new book, Janet Golden argues that the response to fetal alcohol syndrome has been inconsistent, often illogical and frequently volatile.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/policy/25conv.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "MESSAGE IN A BOTTLE: THE MAKING OF FETAL ALCOHOL SYNDROME (BOOK)"}, {"name": "persons", "value": "GOLDEN, JANET"}, {"name": "subject", "value": "ALCOHOL ABUSE"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "FETAL ALCOHOL SYNDROME"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "ALCOHOLIC BEVERAGES"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jan", "rank": 1, "lastname": "HOFFMAN"}], "original": "By JAN HOFFMAN"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health; Books"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "As a psychopharmacologist, I know that every patient responds slightly differently to medication. But it wasn't until I met Susan that I understood just how differently. She'd come to see me because she was depressed, and I'd successfully treated her with a course of Zoloft, a popular antidepressant. But as often happens, Susan's desire for sex had vanished along with her depressed mood.", "headline": {"main": "Sometimes, a Pill Can Hold Surprises for Patient and Doctor Alike", "kicker": "CASES"}, "abstract": "Dr Richard A Friedman Cases column discusses patient suffering from depression and concerns about diminished sexual interest while on antidepressant medication; treatment change to Wellbutrin, which allowed patient to recover sex drive, described; research estimates that 40 to 50 percent of all patients taking selective serotonin reuptake inhibitors suffer sexual side effects; drawing (M)", "print_page": "5", "word_count": 723, "_id": "4fd2809e8eb7c8105d84c432", "snippet": "One doctor discusses an antidepressant's surprising side effect for a female patient.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/01/25/health/25case.html", "multimedia": [{"url": "images/2005/01/24/science/25case.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/01/24/science/25case.75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "subject", "value": "SEX"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "SEROTONIN (CHEMICAL)"}, {"name": "subject", "value": "WELLBUTRIN (DRUG)"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Richard", "middlename": "A.", "lastname": "FRIEDMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD A. FRIEDMAN, M.D"}, "document_type": "article", "pub_date": "2005-01-25T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 12, "offset": 0, "time": 74}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}